首页> 外文期刊>Brazilian Journal of Anesthesiology >Comparison of the postoperative analgesic effects of naproxen sodium and naproxen sodium-codeine phosphate for arthroscopic meniscus surgery
【24h】

Comparison of the postoperative analgesic effects of naproxen sodium and naproxen sodium-codeine phosphate for arthroscopic meniscus surgery

机译:萘普生钠和萘普生钠-可待因磷酸钠在关节镜半月板手术中的镇痛效果比较

获取原文
           

摘要

Background and objectives Nonsteroidal anti-inflammatory drugs (NSAIDs) are frequently used to control arthroscopic pain. Addition of oral effective opioid “codeine” to NSAIDs may be more effective and decrease parenteral opioid consumption in the postoperative period. The aim of this study was to compare the efficacy and side effects of naproxen sodium and a new preparation naproxen sodium-codeine phosphate when administered preemptively for arthroscopic meniscectomy. Methods Sixty-one patients were randomized into two groups to receive either oral naproxen sodium (Group N) or naproxen sodium-codeine phosphate (Group NC) before surgery. The surgery was carried out under general anesthesia. Intravenous meperidine was initiated by patient-controlled analgesia (PCA) for all patients. The primary outcome measure was pain score at the first postoperative hour assessed by the Visual Analogue Scale (VAS). Sedation assessed by Ramsey Sedation Scale, first demand time of PCA, postoperative meperidine consumption, side effects and hemodynamic data were also recorded. Results The groups were demographically comparable. Median VAS scores both at rest and on movement were significantly lower in Group NC compared with Group N, except 18 th hour on movement ( p <0.05). The median time to the first demand of PCA was shorter in Group N compared with Group NC ( p <0.001). Meperidine consumption was higher in Group N compared with Group NC ( p <0.001). There was no difference between groups with respect to side effects ( p >0.05). Conclusions The combination of naproxen sodium-codeine phosphate provided more effective analgesia than naproxen sodium and did not increase side effects.
机译:背景和目的非甾体类抗炎药(NSAIDs)经常用于控制关节镜疼痛。在NSAIDs上添加口服有效的阿片类药物“可待因”可能更有效,并减少术后肠胃外阿片类药物的消耗。这项研究的目的是比较先行进行关节镜半月板切除术时萘普生钠和一种新制剂萘普生钠-可待因磷酸酯的疗效和副作用。方法将61例患者随机分为两组,分别于术前接受口服萘普生钠(N组)或萘普生钠-可待因磷酸钠(NC组)。手术是在全身麻醉下进行的。所有患者均由患者自控镇痛(PCA)启动静脉注射哌啶。主要结果指标是术后第一个小时的疼痛评分,由视觉模拟量表(VAS)评估。还记录了通过Ramsey镇静量表评估的镇静,PCA的首次需求时间,术后哌替啶的消耗,副作用和血液动力学数据。结果各组在人口统计学上具有可比性。 NC组的静息和运动VAS评分均比N组低,除了运动第18小时外(p <0.05)。与NC组相比,N组中第一次PCA需求的中位时间短(p <0.001)。 N组的哌啶消耗量高于NC组(p <0.001)。两组之间在副作用方面没有差异(p> 0.05)。结论萘普生钠-可待因磷酸酯的联合使用比萘普生钠更有效的镇痛作用,并且没有增加副作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号